219 related articles for article (PubMed ID: 33055469)
1. Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
Ishikawa T; Endo S; Imai M; Azumi M; Nozawa Y; Sano T; Iwanaga A; Honma T; Yoshida T
Intern Med; 2020; 59(20):2465-2469. PubMed ID: 33055469
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.
Nakai M; Suda G; Ogawa K; Yoshida S; Hosoda S; Kubo A; Tokuchi Y; Kitagataya T; Yamada R; Shigesawa T; Ohara M; Sho T; Morikawa K; Sakamoto N
PLoS One; 2022; 17(7):e0270786. PubMed ID: 35776720
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites.
Yokoyama K; Fukuda H; Yamauchi R; Higashi M; Miyayama T; Higashi T; Uchida Y; Shibata K; Tsuchiya N; Fukunaga A; Umeda K; Takata K; Tanaka T; Shakado S; Sakisaka S; Hirai F
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143954
[TBL] [Abstract][Full Text] [Related]
4. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.
Kaji K; Takaya H; Saikawa S; Furukawa M; Sato S; Kawaratani H; Kitade M; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
World J Gastroenterol; 2017 Dec; 23(47):8355-8366. PubMed ID: 29307995
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese.
Nishida S; Hamada K; Nishino N; Fukushima D; Koyanagi R; Horikawa Y; Shiwa Y; Saitoh S
World J Hepatol; 2019 Jun; 11(6):531-541. PubMed ID: 31293721
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis.
Tatsumi R; Suii H; Yamaguchi M; Arakawa T; Nakajima T; Kuwata Y; Toyota J; Hige S
Intern Med; 2021 May; 60(10):1501-1507. PubMed ID: 33361677
[TBL] [Abstract][Full Text] [Related]
7. Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
Hayakawa Y; Tamaki N; Nakanishi H; Kurosaki M; Tanaka Y; Inada K; Ishido S; Kirino S; Yamashita K; Nobusawa T; Matsumoto H; Kakegawa T; Higuchi M; Takaura K; Tanaka S; Maeyashiki C; Kaneko S; Yasui Y; Takahashi Y; Tsuchiya K; Okamoto R; Izumi N
Intern Med; 2023 Apr; 62(7):973-978. PubMed ID: 36070941
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
[TBL] [Abstract][Full Text] [Related]
9. Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatments.
Eriksen PL; Djernes L; Vilstrup H; Ott P
J Hepatol; 2023 Aug; 79(2):340-348. PubMed ID: 37061198
[TBL] [Abstract][Full Text] [Related]
10. Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma.
Shah PA; Cho J; Albitar HAH; Pajot G; Liu M; Ravi K
Am J Med; 2020 Dec; 133(12):e745-e746. PubMed ID: 32739410
[No Abstract] [Full Text] [Related]
11. Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.
Kawaratani H; Kondo Y; Tatsumi R; Kawabe N; Tanabe N; Sakamaki A; Okumoto K; Uchida Y; Endo K; Kawaguchi T; Oikawa T; Ishizu Y; Hige S; Takami T; Terai S; Ueno Y; Mochida S; Takikawa Y; Torimura T; Matsuura T; Ishigami M; Koike K; Yoshiji H
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329897
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Encephalopathy in Children.
Bartlett JA; Kohli R
Indian J Pediatr; 2024 Mar; 91(3):280-285. PubMed ID: 37310582
[TBL] [Abstract][Full Text] [Related]
13. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE
J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
[TBL] [Abstract][Full Text] [Related]
14. Rifaximin versus metronidazole in management of acute episode of hepatic encephalopathy: An open labeled randomized clinical trial.
Mekky MA; Riad AR; Gaber MA; Abdel-Malek MO; Swifee YM
Arab J Gastroenterol; 2018 Jun; 19(2):76-79. PubMed ID: 29935863
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome.
Yu X; Jin Y; Zhou W; Xiao T; Wu Z; Su J; Gao H; Shen P; Zheng B; Luo Q; Li L; Xiao Y
Front Cell Infect Microbiol; 2021; 11():761192. PubMed ID: 35118004
[TBL] [Abstract][Full Text] [Related]
16. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
[TBL] [Abstract][Full Text] [Related]
17. Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma.
Narita R; Kotoh K; Yoneda A; Motomura M; Harada M
Anticancer Res; 2020 Sep; 40(9):5271-5276. PubMed ID: 32878816
[TBL] [Abstract][Full Text] [Related]
18. Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy.
Bajaj JS; Sikaroodi M; Shamsaddini A; Henseler Z; Santiago-Rodriguez T; Acharya C; Fagan A; Hylemon PB; Fuchs M; Gavis E; Ward T; Knights D; Gillevet PM
Gut; 2021 Jun; 70(6):1162-1173. PubMed ID: 32998876
[TBL] [Abstract][Full Text] [Related]
19. Albumin-Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study.
Fujita K; Nomura T; Morishita A; Oura K; Yoneyama H; Kobara H; Tsutsui K; Himoto T; Masaki T
Am J Trop Med Hyg; 2019 Jul; 101(1):220-225. PubMed ID: 31115300
[TBL] [Abstract][Full Text] [Related]
20. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]